Plasma esterases and inflammation in ageing and frailty
- 332 Downloads
Esterases are enzymes of drug metabolism known to be reduced in frail older people and during acute illness. The mechanism for this is unknown. The aim of this study was to examine esterase activity and inflammation in ageing and frailty.
Thirty frail patients (mean age 84.9 years) dependent on continuing inpatient care, 40 patients of intermediate frailty attending Day Hospital (84.2 years), 40 fit older controls (82.7 years) and 30 young controls (23.3 years) were studied. Frailty indicators, plasma esterase activities and markers of inflammation were measured.
With increasing patient frailty, C-reactive protein (CRP), interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-α) increased significantly and esterase activity, with the exception of aspirin esterase, fell significantly (p < 0.005). There were significant negative correlations between log-transformed IL-6 and acetylcholinesterase (r = −0.354, p < 0.01), butyrylcholinesterase (r = −0.392, p < 0.01) and benzoylcholinesterase activity (r = −0.241, p < 0.05) and significant negative correlations between TNF-α and acetylcholinesterase (r = −0.223, p < 0.01), butyrylcholinesterase (r = −0.279, p < 0.01) and benzoylcholinesterase activity (r = −0.253, p < 0.01). Aspirin esterase activity did not correlate with IL-6 or TNF- α.
Frailty was associated with higher inflammatory markers and lower esterase activity. There was a weak but significant negative correlation between both IL-6 and TNF-α and the activity of three of four esterases. The negative correlation between esterase activity and inflammatory markers may have a causal basis, comparable to the inflammatory suppression of cytochrome P-450 enzymes.
KeywordsEsterases Frailty Inflammation
- 1.Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA, Ershler WB, Harris T, Fried LP (2006) Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 54(6):991–1001PubMedCrossRefGoogle Scholar
- 8.Morley JE, Baumgartner RN (2004) Cytokine-related aging process. J Gerontol A Biol Sci Med Sci 59(9):924–929Google Scholar
- 10.Roubenoff R, Parise H, Payette HA, Abad LW, D’Agostino R, Jacques PF, Wilson PW, Dinarello CA, Harris TB (2003) Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med 115(6):429–435PubMedCrossRefGoogle Scholar
- 24.Publications of the Parliament of the United Kingdom. Available at: parliament.uk/pa/cm200405/cmselect/cmhealth/399/39902.htm
- 25.Simonsick EM, Gardner AW, Poehlman ET (2000) Assessment of physical function and exercise tolerance in older adults: reproducibility and comparability of 5 measures. Aging Clin Exp Res 12:274–280Google Scholar
- 26.Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T, Westlake L (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J 305:160–164Google Scholar
- 27.Pedersen AN, Ovesen L, Shroll M, Avlund K, Era P (2002) Body composition of 80-years old men and women and its relation to muscle strength, physical ability and functional ability. J Nutr Health Ageing 6:413–420Google Scholar
- 30.Kalow W, Lindsay HA (1955) A comparison of optical and manometric methods for the assay of human serum cholinesterase. Can J Med Sci 33(4):568–574Google Scholar
- 32.Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, Gottdiener J, Fried LP (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162(20):2333–2341PubMedCrossRefGoogle Scholar